⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTRS News
Viatris Inc. Common Stock
Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight
globenewswire.com
BIIB
VRTX
AZN
VTRS
NKTR
CLMB
Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
BIIB
NVS
VTRS
UCB
BMY
ABBV
AZN
CABA
AUR
GSK
VERA
KYMR
NKTR
VRTX
ARWR
Rapid Growth in Paclitaxel Injection Market: From $7.68 Billion in 2026 to $12.72 Billion by 2030
globenewswire.com
PFE
BMY
ABT
VTRS
Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)
prnewswire.com
VTRS
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
prnewswire.com
VTRS
Blue Matter lance une pratique d'expertise en ressources humaines et organisationnelles pour accompagner les entreprises biopharmaceutiques dans leur transformation structurelle
businesswire.com
VTRS
PGR
BHC
Blue Matter führt die People and Organization Practice ein, um Biopharma-Unternehmen bei der Bewältigung des Strukturwandels zu unterstützen
businesswire.com
VTRS
PERI
Blue Matter Launches People and Organization Practice to Help Biopharma Navigate Structural Shift
businesswire.com
BHC
VTRS
PERI
Form 8-K
sec.gov
VTRS
Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results
prnewswire.com
VTRS